JAMA Clinical Reviews cover image

Update on Peanut Allergy

JAMA Clinical Reviews

00:00

Omalizumab: Use and Duration

Abrams explains omalizumab injections prevent allergic cell activation, desensitize while used, and require ongoing dosing.

Play episode from 14:50
Transcript

The AI-powered Podcast Player

Save insights by tapping your headphones, chat with episodes, discover the best highlights - and more!
App store bannerPlay store banner
Get the app